Previous studies examining differences in Lum-A carcinomas found that pathways similar to those active in group 3 tumors were also active in ILC (as compared with ductal carcinoma), including immune-related and metabolic pathways [47]. Here, CCL27 is linked to breast ductal adenocarcinoma.